IGT, impaired glucose tolerance; NGT, normal glucose tolerance; NIDDM, non-insulin-dependent diabetes mellitus.
staging system is proposed in order to improve treatment and favor prevention.
The inheritance of NIDDM The prevalence of NIDDM varies greatly between different parts of the world. The question therefore rises, are these ethnical differences due to different genetic background or to differences in environmental factors? The genetic contribution is quite obvious in some of these populations. There is a higher prevalence of NIDDM among pure Nauruans than in Nauruans with foreign genetic admixture. Furthermore, there is a higher prevalence of NIDDM in full-blood North Dakota Indians aged over 35 yr than in persons with less than one-half Indian inheritance (22.2 vs 4.1% ). Insulin resistance in Pima Indians shows a trimodal distribution consistent with the hypothesis that insulin resistance is determined by a single gene. Similar data are so far lacking in Europid subjects. Given the heterogenous nature of the disease, it is rather likely that several genes contribute to insulin resistance in Europid subjects with NIDDM. The genetic nature of NIDDM in Europids is supported by the following investigations. The concordance rate of NIDDM in monozygotic twins has been found to be around 70-80%, compared with 10-20% in dizygotic twins. There is a clear clustering of imparied glucose tolerance (IGT) and NIDDM in families. In offsprings and in sibs of patients with NIDDM the lifetime risk of developing NIDDM has been estimated to -40% (3). If both parents suffer from the disease the risk in insulin resistant children reaches 80% (6) . Thus, NIDDM seems to be a strongly inherited disease, although the mode of inheritance is not known.
Pathophysiology of NIDDM: what is the primary inherited defect?
Although both peripheral insulin resistance and insulin deficiency contribute to hyperglycemia in NIDDM, hyperglycemia per se can further impair insulin sensitivity and beta-cell function. A vicious cycle ensues, which is able to maintain hyperglycemia. Therefore, subjects with manifest hyperglycemia usually display all defects of diabetes, i.e., insulin resistance and impaired beta-cell function. However, what comes first, insulin resistance or impaired beta-cell function?
Insulin resistance. To address this question we have studied persons at increased risk of developing NIDDM, i.e., first degree relatives of patients with NIDDM (4, 5) . In the Finnish study, the relatives could be divided into two groups based upon whether glucose tolerance was normal or impaired. As expected, patients with NIDDM and IGT were insulin resistant compared with healthy subjects, but surprisingly, relatives with normal oral glucose tolerance (NGT) also showed a significant impairment in their ability to metabolize glucose (4) . In the Danish study lean and younger relatives were investigated. However, the results were identical confirming that even young lean first degree relatives to NIDDM patients were insulin resistant in peripheral tissues (5) . Similar findings have recently been reported in offspring of Mexican Americans with NIDDM (7). The defect in insulin action was localized only to the nonoxidative pathway in skeletal muscles, i.e., glycogen synthesis. In accordance to that we found that the covalent activation of the enzyme glycogen synthase was reduced in parallel to the reduction in glycogen synthesis (5) .
These results clearly indicate that -50% of first degree relatives are insulin resistant 3-4 decades before they are expected to develop Type 2 diabetes. But is insulin resistance a risk factor for progression to NIDDM? This question has been addressed in three prospective studies. The Joshlin group studied offspring of two parents with NIDDM (7). They found that insulin resistant (and glucose resistant) subjects had an 80% increased risk of developing NIDDM during a 25-yr follow up period. In accordance with this, Skarfors et al. (9) demonstrated that a low glucose clearance rate during an intravenous glucose tolerance test was an independent risk factor for developing NIDDM in elderly Swedish men (9) . Similarly, in The Malmo NIDDM Prevention Study a high insulin response during an oral glucose tolerance test (indicating insulin resistance) predicted development of NIDDM in middle-aged men (10) . Taken together, these results strongly indicated that peripheral insulin resistance is an inherited defect predicting development of frank diabetes mellitus.
Insulin secretion. In relatives with normal glucose tolerance (IVGT) all phases of insulin secretion estimated by hyperglycemic clamp were normal (4). This finding is in accordance with the results obtained in the prospective Joslin study (6) , where both first phase and second phase responses to an IVGTT challenge were found to be increased in prediabetics with normal glucose tolerance (NGT). In fact, subjects who developed NIDDM within a 10-20-yr period tended to present higher initial insulin responses to glucose compared with the subjects who continued to be normoglycemic. However, this finding does not exclude an early beta cell defect since insulin secretion rates must be viewed in relation to the degree of insulin resistance. By doing that, even NGT relatives may present a lower than expected insulin secretion rate (our own unpublished data). Relatives with IGT were in our study always associated with impaired first phase insulin secretion and once the patients had progressed to manifest diabetes, all phases of insulin secretion became impaired. In the Swedish studies of elderly subjects a reduced first phase insulin response during IVGIT in addition to insulin resistance was found to predict development of NIDDM (9, 10) . We recently confirmed this finding in a study of elderly identical twins discordant for NIDDM, demonstrating a high concordance rate for insulin deficiancy in the nondiabetic twin (8) . Altogether, these data suggest that insulin resistance alone is not enough to manifest glucose intolerance including NIDDM, an additional defect in insulin secretion is required. This defect seems to be inherited and expressed before frank hyperglycemia.
Hepatic glucose production (HGP). Basal HGP was found to be normal in normoglycemic first degree relatives to patients with NIDDM (4, 5, 7) , but also, the inhibition of hepatic glucose production by insulin seems to be unaffected at this stage (7) . On the other hand, patients with impaired glucose tolerance (IGT + NIDDM) often demonstrate an increase in HGP after meals, indicating that the liver is resistant to the action of insulin, or that this increase in HGP is secondary to insulin deficiency (4) . Enhanced rates of basal hepatic glucose production is frequently, but not always reported in patients with manifest diabetes and fasting hyperglycemia. However, a number of methodological problems make the interpretation of hepatic glucose production data difficult ( 11) . HGP seems to be autoregulated, i.e., an increase in gluconeogenesis, as demonstrated in NIDDM subjects, is counterbalanced by a reduction in glycogenolysis whereby HGP is kept normal or near normal. It is not known whether the putative increase in gluconeogenesis in NIDDM patients is of primary origin; i.e., due to an inherited elevation of Model for the development of NIDDM. The data presented suggest that insulin resistance, i.e., impaired stimulation of glycogen formation in skeletal muscle, represents a primary defect in the pathogenesis of NIDDM (4) (5) (6) (7) . The following model for the development of NIDDM can therefore be proposed: two genetic defects are required, most likely including several genes, one causing impaired glycogen formation in skeletal muscles, the other causing impaired beta-cell function, i.e., inability to compensate for insulin resistance. Although they act jointly to cause diabetes, insulin resistance is the trigger which increases the insulin demands thereby unmasking the defect in the beta cell. A normal beta cell may compensate for the insulin resistance by increasing the amount of insulin secreted whereas the "prediabetic" beta cell in the long term cannot, and hyperglycemia ensues. The genetic defect responsible for insulin resistance in glycogen synthesis in skeletal muscles seems to be expressed very early in life, maybe already in childhood, whereas the genetic defect responsible for the impaired beta-cell function may be expressed later on. Our current hypothesis for the pathogenesis of NIDDM is outlined in Fig. 1 . Cellular defects responsible for inherited insulin resistance in skeletal muscle Inherited insulin resistance in NIDDM patients seems to be located mainly in the non-oxidative pathway of glucose metabolism in skeletal muscle, i.e., glycogen synthesis. When frank diabetes develops, several other metabolic defects are added to the genetic defect(s), along with reduced glucose oxidation.
Stimulation of glycogen synthase activity in skeletal muscle by insulin seems to be the result of a cascade of phosphorylation-dephosphorylation reactions (Fig. 2) . The first step is insulin binding to the alpha subunit of the specific membrane receptor resulting in autophosphorylation of three tyrosine residues of the intracellular beta subunit of the receptor. (GLUT 4) to the cell membrane. An insulin-resistant glucose transport system seems to be a characteristic feature of skeletal muscles from obese diabetics, but the reduced transporter activity in skeletal muscle in NIDDM could be secondary to hyperglycemia, since the amount of GLUT-4 protein expressed has been shown to be normal in NIDDM and since a translocation defect has not been uniformly proven (16) . No significant alterations in the genes encoding for GLUT-1 and GLUT-4 have been described in patients with NIDDM (17) .
In keeping with the findings with IRS-1, the GLUT-4 mRNA tends to be increased in insulin-resistant subjects (16 (18) .
Glycolysis and glucose oxidation. We and others have recently found that the non-oxidative glycolytic flux rate in skeletal muscles in NIDDM patients is increased, which may compensate for the reduction in glucose storage. In accordance with this, the rate limiting enzyme in glycolysis, phosphofructokinase, was found to be without mutations in the coding region by SSCP scanning. Glucose oxidation in response to insulin, on the other hand, is reduced in diabetics which may be caused by a reduced activity of the enzyme pyruvate-dehydrogenase.
In prediabetic subjects, glucose oxidation is completely normal and therefore reduced glucose oxidation in NIDDM may be of secondary origin.
Glycogen synthase. In lean control subjects, insulin stimulates the fractional velocity of glycogen synthase more than twofold. However, in obese diabetic subjects, insulin is unable to increase the enzyme activity. Thus, glycogen synthase seems to be completely resistant to insulin (19) . This defect is due to an abnormal covalent stimulation. The enzyme therefore seems to be partly locked into its inactive G-6-P-dependent form, but may, however, still be activated allosterically by physiological concentrations of G-6-P. In other words, an identical activity rate of glycogen synthase may be obtained in diabetic subjects as in nondiabetic subjects if the intracellular G-6-P concentration in diabetic subjects is increased sufficiently. The reduced glycogen synthase activity seems to be associated with a reduced protein phosphatase-l activity (PPl ) and an increased c-AMP-dependent protein kinase activity in skeletal muscles from obese diabetic subjects compared with nondiabetic subjects. The We have recently described the exon-intron structure of the GS gene and found a missense mutation in exon 11 in two families with NIDDM, hypertension, and premature arteriosclerosis (23) . Screening of the promoter region with SSCP scanning has also revealed a number of polymorphisms, none of which seems to be increased in patients with NIDDM. Expression of the glycogen synthase gene is not decreased in patients with NIDDM, and no difference in the expression of the glycogen synthase gene has been observed between patients with different alleles of XbaI glycogen synthase polymorphism (24).
Genetic defects in insulin secretion
The finding of linkage between the glucokinase gene on chromosome 7 and MODY (maturity-onset diabetes in the young) was a real breakthrough in the search for diabetes-associated genes (25) . Several mutations have been described in the glucokinase gene, some even occurring in the same MODY family. Of importance, the mutant enzyme in general has a lower affinity for glucose resulting in impaired glucose stimulated insulin secretion. Glucokinase mutations are observed in 60% of patients with MODY. This form of diabetes, that is further characterized by mild impairment in fl-cell function, could preferentially be called glucokinase-deficient diabetes. It is questionable whether glucokinase mutations are seen in patients with classical NIDDM; the phenotype of NIDDM patients with glucokinase defects has in general been very MODY-like.
Mitochondrial mutations
Maternal transmission of NIDDM predominates, therefore mutations in mitochondrial DNA have merged as possible targets for a genetic defect leading to NIDDM. Mitochondrial DNA, which is circular and contains only 16,569 bp, is transmitted only from the mother. Mutations in mitochondrial DNA have been reported in both IDDM and NIDDM patients with deafness (26). These patients are generally characterized by some degree of beta-cell dysfunction, but it is not known how the mutation affects mitochondrial energy metabolism. Mitochondrial mutations tend to increase with age. In the same cell there can be both normal and abnormal mitochondrial DNA (heteroplasmy). Theoretically, an increasing number of mitochondrial DNA mutations could influence energy metabolism both in the beta cell and in the muscle, thereby increasing the risk for NIDDM with age.
The thrifty gene theory
Why is NIDDM increasing in individuals switching from a rural to an urban lifestyle? The thrifty gene hypothesis was put forward in 1962 by Neel (27) , who proposed that for societies living in environments with unstable food supplies, maximizing storage of surplus energy would enhance the probability of survival under periods of energy deficiency. With the abundance of food typical for modem Westernized society, such a genotype might lead to marked obesity and glucose intolerance. If this hypothesis is true, it may be more economical to channel energy to fat than to glycogen in skeletal muscle. Furthermore, insulinresistant patients should have increased amounts of triglycerides in their muscles. In fact, patients with NIDDM have a four-to fivefold increase in skeletal muscle triglyceride concentrations compared with healthy control subjects, but data are lacking from insulin-resistant nondiabetic subjects. Support for the survival advantage hypothesis comes from a study of heterogeneous insulin-resistant ob and ob mice (28) . When given a surplus of food, part of these animals develop hyperinsulinemia and hyperglycemia. If the thrifty gene hypothesis is correct, insulin-resistant animals should be better suited to withstand prolonged periods of starving. In fact, the insulin-resistant ob and ob mice survived longer during starvation than their insulinsensitive littermates. Interestingly, the locus for developing diabetes during fat feeding in certain mice strains was recently linked to chromosome 7 or, more precisely, to the glycogen synthase locus (29) .
The search for NIDDM genes Although there is plenty of evidence that NIDDM is inherited, there is also a number of arguments against a Mendelian mode of inheritance. The disease is more often transmitted from the mother than from the father. The penetrance of the disease is highly variable and age dependent, and dependent upon environmental factors as energy intake and exercise.
Is it a realistic task to search for the NIDDM genes? There will be nothing like a one-gene-one-disease, it is even unlikely that there will be any major gene. The genetic abnormalities will most likely be unmasked only when exposed to changes in environmental factors. There can be 4-5 genes involved that increase the susceptibility to develop diabetes under certain environmental conditions. The candidate gene approach so far has been only partially successful, but the list of candidate genes seems to be depleted soon. A random gene search has been successful for a number of monogenic diseases with well-known inheritance, but will it work for NIDDM? A conventional linkage analysis would require that the gene(s) involved would explain a major part of the disease. It requires further information about mode of inheritance and penetrance, two unknowns in the NIDDM gene equation.
There are some ways to improve the odds. If the population studied is homogenous, random markers at 10-cM intervals or less could be tried. Sibpair or affected pedigree member analysis (2) .
But how can NIDDM be prevented? If we accept that NIDDM is a result of genetic predisposition exposed to an imbalance between energy intake and expenditure, we have some options. It may take some time before the genetic predisposition is unraveled. In the meantime, we can recommend the patients to reduce energy intake or increase expenditure, i.e., performing physical exercise in order to avoid obesity. An increase in energy expenditure and/or a reduction of energy intake has been proven in prospective studies to prevent development of NIDDM and reduce mortality in prediabetic subjects (34, 35) .
